Featured Article
Zoetis, a global leader in the animal health industry, had a positive FY 2026. Revenue rose 2.3% to $9.5 Y billion, and operating profits rose 5.4% to $3.8 billion over last year. A review of Zoetis’s 2 February 2026 earnings call and annual 10-K filing provided insight regarding the importance of pricing on performance. FACTS FROM EARNINGS CALL AND ANNUAL REPORT Wetteny Joseph, CFO, said of pricing, “Our pricing has always been…
In This Issue
LabCorp, a laboratory services company for medical providers, pharmaceuticals, and researchers, had a positive FY 2024. Revenue rose 7% to $13.0 billion,…
Moderna, a leader in mRNA medicine best known for its COVID vaccine, had a mixed FY 2024. Revenue fell 53% to $3.2…
Tariffs are in the news, but will they have no to little impact on inflation? What can we expect in the next…
Bristol-Myers Squibb, a global biopharmaceutical company, had a mixed FY 2024. Revenue rose 7.3% to $48.3 billion while operating earnings fell 199%…